Protective Effects of Combined Treatment with Ciprofol and Mild Therapeutic Hypothermia During Cerebral Ischemia-reperfusion Injury
Overview
Affiliations
Despite improvement in cardiopulmonary resuscitation (CPR) performance, cardiac arrest (CA) is still associated with poor prognosis. The high mortality rate is due to multi-organ dysfunction caused by cerebral ischemia and reperfusion injury (I/R). The guidelines for CPR suggest the use of therapeutic hypothermia (TH) as an effective treatment to decrease mortality and the only approach confirmed to reduce I/R injury. During TH, sedative agents (propofol) and analgesia agents (fentanyl) are commonly used to prevent shiver and pain. However, propofol has been associated with a number of serious adverse effects such as metabolic acidosis, cardiac asystole, myocardial failure, and death. In addition, mild TH alters the pharmacokinetics of agents (propofol and fentanyl) and reduces their systemic clearance. For CA patients undergoing TH, propofol can be overdosed, leading to delayed awakening, prolonged mechanical ventilation, and other subsequent complications. Ciprofol (HSK3486) is a novel anesthetic agent that is convenient and easy to administer intravenously outside the operating room. Ciprofol is rapidly metabolized and accumulates at low concentrations after continuous infusion in a stable circulatory system compared to propofol. Therefore, we hypothesized that treatment with HSK3486 and mild TH after CA could protect the brain and other organs.
Safety and efficacy of ciprofol versus propofol for gastrointestinal endoscopy: a meta-analysis.
Cheng X, Zhang P, Jiang D, Fang B, Chen F BMC Gastroenterol. 2025; 25(1):130.
PMID: 40033212 PMC: 11877735. DOI: 10.1186/s12876-025-03734-0.
Pharmacological Insights and Clinical Applications of Ciprofol: A Narrative Review.
Petkar S, Bele A, Priya V, Bawiskar D Cureus. 2024; 16(8):e68034.
PMID: 39347129 PMC: 11432775. DOI: 10.7759/cureus.68034.
Pan M, Liu W, Zhang Z, Li T, Xie W BMC Anesthesiol. 2024; 24(1):197.
PMID: 38834948 PMC: 11149185. DOI: 10.1186/s12871-024-02583-w.